The European Medicines Agency's goals for regulatory science to 2025

Philip A. Hines*, Richard H. Guy, Anthony J. Humphreys, Marisa Papaluca-Amati

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Abstract

It is increasingly important that regulatory agencies catalyse the translation of scientific and technological innovation into improved patient-centred health care. Here, we highlight the strategic goals of the European Medicines Agency to advance regulatory science and optimize the opportunities arising in areas such as cell and gene therapies, big data and artificial intelligence.

Original languageEnglish
Pages (from-to)403-404
Number of pages2
JournalNature Reviews Drug Discovery
Volume18
Issue number6
DOIs
Publication statusPublished - Jun 2019

Fingerprint

Dive into the research topics of 'The European Medicines Agency's goals for regulatory science to 2025'. Together they form a unique fingerprint.

Cite this